[SaNOtize in BioSpace] SaNOtize Phase II COVID Prevention and Treatment Trial Underway in BC, Quebec Enrolment to Begin June 1
VANCOUVER, May 25, 2020 /CNW/ – SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced it enrolled its first participant on May 12, 2020 in a multi-centre Phase II trial of its Nitric Oxide Releasing Solution (NORSTM) for the prevention and early treatment of COVID-19. The Company is continuing enrolment in British Columbia and will initiate enrolment in Quebec on June 1. Read...
Read More